Arabic Arabic English English French French German German
dark

Founder and Executive Chairman of Emergent BioSolutions Announces RetirementFuad El-Hibri to Retire After More Than 20 Years

Emergent BioSolutions Inc. (NYSE: EBS) today announced that Fuad El-Hibri, founder and executive chairman, has decided to retire effective April 1, 2022. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Digital Health’s monthly roundup of contracts and go lives

Next Post

Alnylam to Present Full 18-Month Results from the HELIOS-A Phase 3 Study of Vutrisiran at the Société Francophone du Nerf Périphérique Annual Meeting

Related Posts
Total
0
Share